Contact us | Sign in | A A A | U.S.A. U.S.A. (Change) - English
About us Our Businesses Community Investors News/Media Careers

Controlled substance shipments alert

Cardinal Health has communicated the following updates directly to customers concerning our suspension of controlled substance shipments from certain Cardinal Health facilities.

Cardinal Health has been reviewing its controlled-substance ordering procedures, and as a result is implementing near- and long-term enhancements that further guard against distribution to pharmacies that are engaged in diversion. The safety of the pharmaceutical supply chain is among Cardinal Health's top priorities and we are committed to the highest standards as we work with the DEA to resolve this matter.

Kerry Clark, CEO of Cardinal Health

An Open letter to our customers

R. Kerry Clark, Chairman and Chief Executive Officer, Cardinal Health

Thank you for your patience and understanding as we take steps to guard against the diversion of controlled substances. Diversion is an issue that has received considerable attention over the past year and is one of the top issues facing all of us in the pharmaceutical industry. »View more